| Year |
Citation |
Score |
| 2014 |
Balu DT, Takagi S, Puhl MD, Benneyworth MA, Coyle JT. D-serine and serine racemase are localized to neurons in the adult mouse and human forebrain. Cellular and Molecular Neurobiology. 34: 419-35. PMID 24436034 DOI: 10.1007/S10571-014-0027-Z |
0.738 |
|
| 2013 |
Balu DT, Li Y, Puhl MD, Benneyworth MA, Basu AC, Takagi S, Bolshakov VY, Coyle JT. Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction. Proceedings of the National Academy of Sciences of the United States of America. 110: E2400-9. PMID 23729812 DOI: 10.1073/Pnas.1304308110 |
0.739 |
|
| 2012 |
Coyle JT, Basu A, Benneyworth M, Balu D, Konopaske G. Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications. Handbook of Experimental Pharmacology. 267-95. PMID 23027419 DOI: 10.1007/978-3-642-25758-2_10 |
0.783 |
|
| 2012 |
Benneyworth MA, Coyle JT. Altered acquisition and extinction of amphetamine-paired context conditioning in genetic mouse models of altered NMDA receptor function. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2496-504. PMID 22763616 DOI: 10.1038/Npp.2012.108 |
0.658 |
|
| 2012 |
Benneyworth MA, Li Y, Basu AC, Bolshakov VY, Coyle JT. Cell selective conditional null mutations of serine racemase demonstrate a predominate localization in cortical glutamatergic neurons. Cellular and Molecular Neurobiology. 32: 613-24. PMID 22362148 DOI: 10.1007/S10571-012-9808-4 |
0.777 |
|
| 2011 |
Benneyworth MA, Roseman AS, Basu AC, Coyle JT. Failure of NMDA receptor hypofunction to induce a pathological reduction in PV-positive GABAergic cell markers. Neuroscience Letters. 488: 267-71. PMID 21094213 DOI: 10.1016/J.Neulet.2010.11.043 |
0.781 |
|
| 2011 |
Benneyworth MA, Basu AC, Coyle JT. Discordant behavioral effects of psychotomimetic drugs in mice with altered NMDA receptor function. Psychopharmacology. 213: 143-53. PMID 20865248 DOI: 10.1007/S00213-010-2023-4 |
0.789 |
|
| 2010 |
Coyle JT, Balu D, Benneyworth M, Basu A, Roseman A. Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia. Dialogues in Clinical Neuroscience. 12: 359-82. PMID 20954431 |
0.753 |
|
| 2010 |
Basu AC, Tsai GE, Ma CL, Ehmsen JT, Mustafa AK, Han L, Jiang ZI, Benneyworth MA, Froimowitz MP, Lange N, Snyder SH, Bergeron R, Coyle JT. Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior (Molecular Psychiatry (2009) 14 (719-727) DOI: 10.1038/mp.2008.130) Molecular Psychiatry. 15: 1122. DOI: 10.1038/Mp.2010.84 |
0.7 |
|
| 2009 |
Basu AC, Tsai GE, Ma CL, Ehmsen JT, Mustafa AK, Han L, Jiang ZI, Benneyworth MA, Froimowitz MP, Lange N, Snyder SH, Bergeron R, Coyle JT. Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior. Molecular Psychiatry. 14: 719-27. PMID 19065142 DOI: 10.1038/Mp.2008.130 |
0.8 |
|
| 2008 |
Benneyworth MA, Smith RL, Sanders-Bush E. Chronic phenethylamine hallucinogen treatment alters behavioral sensitivity to a metabotropic glutamate 2/3 receptor agonist. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2206-16. PMID 17957214 DOI: 10.1038/sj.npp.1301600 |
0.635 |
|
| 2007 |
Benneyworth MA, Xiang Z, Smith RL, Garcia EE, Conn PJ, Sanders-Bush E. A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis. Molecular Pharmacology. 72: 477-84. PMID 17526600 DOI: 10.1124/Mol.107.035170 |
0.752 |
|
| 2005 |
Benneyworth MA, Smith RL, Barrett RJ, Sanders-Bush E. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice. Psychopharmacology. 179: 854-62. PMID 15645221 DOI: 10.1007/s00213-004-2108-z |
0.547 |
|
| Show low-probability matches. |